XUANZHU PHARMA CO., LTD.
Patent Owner
Stats
- 20 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jan 04, 2018 most recent publication
Details
- 20 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 54 Total Citation Count
- Jun 26, 2008 Earliest Filing
- 1 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9730934 Quinazoline derivatives substituted by aniline, preparation method and use thereofAug 30, 11Aug 15, 17[A61K, C07D]
9586939 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereofMay 28, 12Mar 07, 17[A61K, C07D]
9527876 Prodrugs of bicyclic substituted pyrimidine type PDE-5 inhibitorsMar 28, 14Dec 27, 16[A61K, C07F]
9475812 Pyridonaphthyridine type dual PI3K and mTOR inhibitor and its preparation and useJun 04, 12Oct 25, 16[A61K, C07D]
9359344 Biaryl heterocycle substituted oxazolidinone antibacterial agentsSep 28, 12Jun 07, 16[A61K, C07F, C07D]
9315438 Optically pure benzyl-4-chlorophenyl-C-glucoside derivativeJan 03, 14Apr 19, 16[A61K, C07D, C07C]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0079,322 CRYSTALLINE OF CARBAPENEM DERIVATIVE OR ITS HYDRATE, PREPARATION METHODS AND USES THEREOFAbandonedMay 20, 11Mar 28, 13[C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.